Related Experiment Video
Updated: May 19, 2026
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Ventilator-associated pneumonias in children (II)--prophylaxis and treatment
Tonyo I Shmilev1, Ivan V Yankov
1Department of Pediatrics and Medical Genetics, Medical University, Plovdiv, Bulgaria. t.shmilev@gmail.com
Insights
Ventilator-associated pneumonia (VAP) is a common intensive care unit infection in children. Effective VAP prevention involves strict hygiene, proper equipment management, and specific intubation techniques, not routine antibiotic prophylaxis.
Area of Science:
- Pediatrics
- Infectious Diseases
- Critical Care Medicine
Background:
- Ventilator-associated pneumonia (VAP) is a significant nosocomial infection in pediatric intensive care units (PICUs).
- Risk factors include patient condition, equipment, and treatment protocols.
- Understanding VAP's epidemiology is crucial for effective management.
Purpose of the Study:
- To outline evidence-based strategies for VAP prophylaxis in children.
- To discuss current therapeutic approaches for managing VAP.
- To emphasize the importance of infection control in PICUs.
Main Methods:
- Review of established VAP prevention guidelines.
- Analysis of risk factors associated with VAP development.
- Discussion of antibiotic use in VAP prophylaxis and treatment.
Main Results:
- Rigorous hygiene, specific ventilator circuit management, and appropriate intubation methods are key to VAP prevention.
- Antibiotic prophylaxis does not decrease VAP incidence or poly-resistant bacteria.
- Early, broad-spectrum antibiotic therapy guided by local antibiograms is recommended for treatment.
Conclusions:
- Comprehensive VAP prophylaxis requires a multi-faceted approach focusing on non-antibiotic interventions.
- Antibiotic stewardship is essential in managing VAP to combat resistance.
- Standardized patient care and staff training are vital for reducing VAP rates.
Abstract:
Ventilator-associated pneumonia (VAP) is the second most common nosocomial infection among children treated in intensive care units. The risk factors for developing this condition are generated by the patient's bedside conditions, the equipment used and the specific treatment administered to the child. Prophylaxis of VAP should necessarily include all measures that have been proven to be efficient in this respect such as rigorous hygiene control of hands and protective clothing of attending staff, changing breathing circuits of ventilators only if they malfunction or if they are visibly contaminated, preference of orotracheal intubation (instead of nasotracheal intubation) and use of endotracheal tubes with dorsal lumens to allow respiratory secretions to drain, and introduction of a uniform approach to patient care and staff training. Prophylaxis of the microbial colonization in children by antibiotics does not reduce the incidence of VAP-causing poly-resistant bacteria. Therapeutic management includes early initiation of broad spectrum empirical antibiotic therapy, the right choice of antibiotic requiring regular monitoring and good knowledge of the antibiotics sensitivity of the most common microbial isolates in the ward.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...